Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
The prognosis of non-small-cell lung cancer (NSCLC) with brain metastases is very poor. Currently, therapeutic methods for this patient population include whole-brain radiation therapy (WBRT), surgery, radiosu...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Kejun Liu, Guanming Jiang, Ailing Zhang, Zhuanghua Li and Jun Jia Tags: Research article Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Radiation Therapy